Internal Medicine, Hematology & Oncology · Boise, ID
NPI
1992760664
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1055 N Curtis Rd
Boise, ID, 83706
Phone (208) 367-3131
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
928 services
Medicare patients, 2024
439
Average age 74
Drug cost, 2024
$3.8M
1,574 prescriptions
Company payments, 2025
$698
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew S Pierson was code 99214 (office e&m - established), 380 times for 185 patients. In total Andrew S Pierson billed 928 services in 16 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 380 | 185 | $66.45 | $25K |
| 99213 Office E&M - Established | Facility | 176 | 150 | $42.07 | $7,404 |
| 99215 Office E&M - Established | Facility | 136 | 87 | $103.05 | $14K |
| 99205 Office E&M - New | Facility | 84 | 84 | $131.63 | $11K |
| 99204 Office E&M - New | Facility | 35 | 35 | $78.71 | $2,755 |
| 99441 Telephone Services | Office | 25 | 18 | $32.85 | $821 |
| 99214 Office E&M - Established | Office | 24 | 12 | $72.87 | $1,749 |
| 99213 Office E&M - Established | Office | 16 | 14 | $43.74 | $700 |
| 99215 Office E&M - Established | Office | 13 | 13 | $104.99 | $1,365 |
By year: 2022 $58K for 847 services; 2023 $67K for 952 services; 2024 $67K for 928 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew S Pierson prescribed most often to Medicare patients was Anastrozole, with 146 prescriptions and refills. In total Andrew S Pierson wrote 1,574 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 146 | 308 | 41 | $2,088 |
| Prochlorperazine Maleate Generic | 115 | 115 | 79 | $2,469 |
| Acyclovir Generic | 92 | 126 | 20 | $969 |
| Tamoxifen Citrate Generic | 80 | 146 | 22 | $2,163 |
| Eliquis Apixaban | 72 | 86 | 18 | $50K |
| Dexamethasone Generic | 63 | 85 | 40 | $1,352 |
| Potassium Chloride Generic | 59 | 82 | 20 | $858 |
| Olanzapine Generic | 43 | 45 | 22 | $267 |
| Levothyroxine Sodium Generic | 39 | 62 | 11 | $253 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 43 | Under 11 | $158 |
| Letrozole Generic | 35 | 97 | 13 | $688 |
| Hydroxyurea Generic | 35 | 82 | 11 | $694 |
| Ibrance Palbociclib | 32 | 32 | Under 11 | $478K |
| Prednisone Generic | 30 | 34 | 14 | $113 |
| Trazodone Hcl Generic | 28 | 28 | Under 11 | $114 |
Brand drugs: 374 claims; generic drugs: 1,200 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew S Pierson $698 ($698 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $226.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $226 |
| Genentech USA, Inc. ROG.SW | 3 | $68.1 |
| Celgene Corporation BMY | 3 | $68.07 |
| Genentech, Inc. ROG.SW | 1 | $53.45 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $46.05 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $37.02 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $32.33 |
| Astellas Pharma US Inc 4503.T | 1 | $29.52 |
| Array Biopharma Inc PFE | 1 | $27.5 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $24.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.